HYBRID EVENT: You Can Participate In Person At Budapest, Hungary Or Virtually From Your Home Or Work
ICNDDT · Registering as Listener

International Conference on Neurodegenerative Diseases and Therapeutics

1–2 Sep 2026 Budapest, Hungary Standard / Physical Participation
Listener Registration
$144
virtual · $220 in person
Registration Benefits:
Official invitation letterIssued automatically after registration
Certificate & digital materialsGet certificate, slides and resource materials
Supporting global researchConnect with researchers across 30+ countries

Select registration mode

Prices are shown before tax and bank charges — no surprises at checkout.
All sessions Networking Certificate Invitation letter Conference kit

Your details

We only need what's required to register and email your confirmation. Everything else is optional.

Coupon code

Have a code? Apply it here — the discount updates the total immediately.
Apply
Try FAST10 for 10% off on eligible registrations.

1. Policy on Cancellations & Refunds :

  • A full refund is possible only if the cancellation request is submitted at least 70 days before the conference, with formal paperwork completed at least 60 days prior.
  • If cancellation occurs between 60 and 30 days before the event, partial refunds may be granted based on administrative costs incurred.
  • Cancellations made within 30 days of the event are non-refundable, though participants will receive a credit valid for one year.
  • Registrations made less than 30 days before the event are not eligible for refunds, but may be transferred to another ISIT conference.
  • Since this conference is hybrid format, the organizer reserves the right to conduct the event either in-person or virtually. Please note that no refunds will be issued due to changes in the event format.
  • Virtual registration fees are non-refundable. A credit will instead be issued for use at a future conference event.

2. Participation & Registration Requirements :

  • To attend an ISIT event, participants must complete the registration process within the stipulated time.
  • The event schedule, venue, and format are subject to changes at the discretion of the organizers, with prior notice sent via email.
  • ISIT is not liable for any financial losses resulting from changes in event details.
  • Fees paid for registration are strictly non-refundable.
  • If the primary author cannot participate, a co-author may attend instead, but refunds will not be granted for non-attendance.

3. Submission & Publication Norms :

  • Researchers submitting papers to ISIT must ensure their institution or supervisor is aware of their submission.
  • Each submission is subject to a rigorous peer review before being accepted for presentation.
  • Only papers linked to a completed registration will be included in conference proceedings.
  • The submitting author is considered the primary author; ISIT does not verify individual authorship claims.
  • If any concerns regarding authorship arise and are validated, the paper will be withdrawn without reconsideration.
  • Once a paper is removed, it cannot be reintroduced into any ISIT publication.

4. Travel & Accommodation Responsibilities :

  • Attendees are responsible for making their own travel and lodging arrangements.
  • ISIT does not provide logistical assistance for travel or accommodation.
  • The organization bears no responsibility for expenses incurred due to conference modifications or rescheduling.

5. Visa & Invitation Letter Policy :

  • Attendees are responsible for making their own travel and lodging arrangements.
  • ISIT does not provide logistical assistance for travel or accommodation.
  • The organization bears no responsibility for expenses incurred due to conference modifications or rescheduling.
  • ISIT does not engage directly with consulates or embassies on behalf of attendees.
  • Participants must handle their own visa applications and processes.
  • Important Information Regarding Invitation Letters:
    • The invitation letter is provided solely for conference attendance and does not serve as a document for immigration, employment, or residency purposes.
    • The letter assists in visa applications but does not guarantee visa approval.
    • ISIT holds no responsibility for visa denials or processing delays, and all related costs are borne by the applicant.
    • Any alterations or unauthorized use of the invitation letter will result in its invalidation and possible cancellation of conference participation.
    • Legal action may be pursued if the document is misused.
    • By accepting the invitation letter, attendees agree to comply with international travel regulations and ethical participation standards.

6. Registration Transfers :

  • Registrations may be transferred to another individual from the same institution if the original participant cannot attend.
  • Transfer requests must be made via email to info@isit.org.in with necessary details and supporting documents.
  • Transfers must be requested at least 14 days before the event; otherwise, they will not be accommodated.
  • Transferred registrations are not eligible for refunds.

7. General Considerations :

  • Any modifications or cancellations must be communicated in writing to info@isit.org.in.
  • Registration confirms acknowledgment and acceptance of these policies.
  • ISIT does not initiate automatic transactions; all payments are voluntarily completed by registrants.
  • Once registered, participants must submit a conference registration form within three days for confirmation.
  • Travel plans should only be finalized after receiving the official conference itinerary, which will be shared 15 days before the event.
Payments encrypted & processed securely. Refundable up to 14 days before the event.

What you'll hear about

Session tracks covered across the event.
View all 11 tracks →
This session will explore the underlying biological mechanisms that contribute to neurodegenerative diseases. Emphasis will be placed on recent discoveries in cellular and molecular pathways involved in conditions such as Alzheimer's and Parkinson's.
This track will focus on novel therapeutic strategies for managing neurodegenerative diseases. Presentations will cover cutting-edge research in drug development, gene therapy, and personalized medicine.
This session will examine the role of neuroinflammation in the progression of neurodegenerative diseases. Discussions will highlight the interplay between immune responses and neuronal health.
This track will delve into the cognitive deficits associated with various neurodegenerative diseases. Research findings on assessment tools and interventions aimed at improving cognitive function will be presented.
This session will focus on the identification and validation of biomarkers for early detection of neurodegenerative diseases. The importance of biomarkers in clinical trials and patient management will also be discussed.
This track will explore strategies aimed at protecting neuronal cells from degeneration. Topics will include pharmacological agents, lifestyle interventions, and their implications for patient care.
This session will emphasize the importance of patient-centered care in the management of neurodegenerative diseases. Discussions will include the integration of patient preferences and experiences into therapeutic decision-making.
This track will highlight the latest advancements in neuroimaging technologies for studying neurodegenerative diseases. Presentations will focus on how these techniques enhance our understanding of disease progression and treatment efficacy.
This session will investigate the genetic and environmental factors contributing to the risk of developing neurodegenerative diseases. The interplay between genetic predisposition and lifestyle choices will be a key focus.
This track will address the ethical challenges associated with research in neurodegenerative diseases. Discussions will include informed consent, patient autonomy, and the implications of emerging therapies.
This session will explore future research directions and emerging trends in the field of neurodegenerative diseases. Participants will discuss potential breakthroughs and the impact of interdisciplinary approaches on therapeutic development.